Breakthrough Relief for Severe Depression: Discover Spravato®

Choosing where to receive Spravato® matters, as the treatment requires a certified REMS (Risk Evaluation and Mitigation Strat

Rapid, FDA-Approved Nasal Spray Therapy at Springtime Psychiatry Group

If you or a loved one is battling severe depression that hasn't improved with traditional therapies, hope is closer than you think. Springtime Psychiatry Group offers Spravato® (esketamine), a revolutionary, FDA-approved nasal spray designed to break through the fog of chronic, stubborn depression.

Unlike standard oral medications that can take weeks to work, Spravato® targets unique pathways in the brain to deliver rapid relief.

What is Spravato®?

Spravato® is the first and only FDA-approved esketamine nasal spray developed specifically for severe forms of depression. Traditional antidepressants primarily target brain chemicals like serotonin or norepinephrine. Spravato® works differently by targeting the glutamate system and NMDA receptors in the brain. This rapid-acting treatment promotes neuroplasticity, essentially helping the brain "rewire" itself and repair neural connections damaged by chronic stress and depression.

Because it can cause temporary sedation or a feeling of detachment (dissociation), Spravato® cannot be taken at home. It is safely administered right here in our office under the direct supervision of our certified clinical team.

What Conditions Does It Treat?

Spravato® is strictly indicated and FDA-approved to treat two primary conditions in adults:

Treatment-Resistant Depression (TRD): For individuals diagnosed with major depressive disorder who have not found adequate relief from standard medical interventions.

Depression with Acute Suicidal Thoughts: For individuals experiencing major depressive disorder accompanied by urgent suicidal ideation or behaviors, offering a critical tool for rapid crisis stabilization.

Who Benefits from Spravato®?

You may be an ideal candidate for Spravato® therapy if you meet the following clinical criteria:

You are an adult aged 18 or older.

You have tried multiple antidepressants (typically two or more different daily oral medications during your current depressive episode) without a significant reduction in your symptoms.

You need fast-acting relief to overcome severe, exhausting depressive symptoms or a mental health crisis.

You do not have contraindications such as uncontrolled hypertension, blood vessel aneurysms, or a history of intracerebral hemorrhage.

Why Choose Springtime Psychiatry Group for Your Spravato® Treatment?

Choosing where to receive Spravato® matters, as the treatment requires a certified REMS (Risk Evaluation and Mitigation Strategy) environment. Springtime Psychiatry Group is the smart choice for your care because we provide:

The Most Experienced Providers on Cape Cod and the South Shore: As regional pioneers in esketamine therapy, our clinicians have managed more Spravato® patient journeys than any other practice in the region. This unmatched expertise translates to a deeply intuitive, fine-tuned approach to your individual treatment plan.

Certified REMS Experts: Our clinic is fully certified to administer Spravato®, ensuring your treatment follows rigorous, exact safety protocols.

Comfort-First Observation Rooms: Spravato® requires a two-hour observation period after administration. We provide private, peaceful, and relaxing spaces designed to maximize your comfort and calm during your session.

Comprehensive Care Integration: We do not just administer the spray and send you away. We seamlessly integrate Spravato® into your broader mental health plan, coordinating directly with your existing therapy and medication management.

Insurance Navigation Assistance: Our dedicated administrative team advocates for you, managing the complex prior authorization process to help maximize your insurance coverage.